Parexel International Corp - Strategic SWOT Analysis Review

Parexel International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

Parexel International Corp (Parexel), a subsidiary of Pamplona Capital Management LLP is a biopharmaceutical outsourcing service company. It provides services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Newton, Massachusetts, the US.

Parexel International Corp Key Recent Developments

Dec 14,2020: Parexel joins Decentralized Trials & Research Alliance (DTRA) to enhance patient access, increase diversity and accelerate trial timelines
Sep 24,2020: Parexel and Innoplexus unveil single source of COVID-19 information for researchers, sponsors and patients during the pandemic
Sep 21,2020: Parexel announces solution for EU clinical trials information system regulation
Aug 27,2020: Parexel and Pfizer enter next phase of decade-long partnership
Jul 23,2020: Parexel expands global regulatory capabilities with experts from FDA, EMA, NMPA and Spanish AEMPS

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.



Section 1 - About the Company
Parexel International Corp - Key Facts
Parexel International Corp - Key Employees
Parexel International Corp - Key Employee Biographies
Parexel International Corp - Major Products and Services
Parexel International Corp - History
Parexel International Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Parexel International Corp - Business Description
Parexel International Corp - SWOT Analysis
SWOT Analysis - Overview
Parexel International Corp - Strengths
Parexel International Corp - Weaknesses
Parexel International Corp - Opportunities
Parexel International Corp - Threats
Parexel International Corp - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Parexel International Corp, Recent Deals Summary
Section 4 Companys Recent Developments
Dec 14, 2020: Parexel joins Decentralized Trials & Research Alliance (DTRA) to enhance patient access, increase diversity and accelerate trial timelines
Sep 24, 2020: Parexel and Innoplexus unveil single source of COVID-19 information for researchers, sponsors and patients during the pandemic
Sep 21, 2020: Parexel announces solution for EU clinical trials information system regulation
Aug 27, 2020: Parexel and Pfizer enter next phase of decade-long partnership
Jul 23, 2020: Parexel expands global regulatory capabilities with experts from FDA, EMA, NMPA and Spanish AEMPS
Jul 23, 2020: New staff bring significant oncology, immunotherapy and rare disease expertise to Parexel
Jun 18, 2020: Parexel and TriNetX partner to advance real-world data use in clinical development
May 20, 2020: Parexel and Society for Clinical Research Sites host joint summit of site and Patient Advisory Councils focused on optimizing site and patient relationships in clinical trials
May 20, 2020: Parexel launches new keepingpatientsfirst integrated research platform powered by Microsoft Azure providing rapid access to critical new covid-19 data
May 18, 2020: Virus-like particles developed for RSV may hold key to covid-19 vaccine, UMMS researcher says
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


Parexel International Corp, Key Facts
Parexel International Corp, Key Employees
Parexel International Corp, Key Employee Biographies
Parexel International Corp, Major Products and Services
Parexel International Corp, History
Parexel International Corp, Other Locations
Parexel International Corp, Subsidiaries
Parexel International Corp, Key Competitors
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Parexel International Corp, Recent Deals Summary

List Of Figures


Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

2019 Diagnostics Competitive Intelligence: Parexel International Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization

USD 950 View Report

Parexel International Corp - Strategic SWOT Analysis Review

Parexel International Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Navistar International Corp (NAV) - Financial and Strategic SWOT Analysis Review

Navistar International Corp (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Posco International Corp (047050) - Financial and Strategic SWOT Analysis Review

Posco International Corp (047050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available